| Difference from | ||||||||||
| € millions | Subscribed capital1 | Capital reserves |
Retained earnings |
Successive purchases2 |
remeasure- ment of defined benefit plans3 |
currency translation4 |
financial instru- ments5 |
Total | Non-controlling interests |
Total |
| As at January 1, 2022 | 512.0 | 4,155.6 | 10,283.9 | -311.8 | -1,994.9 | -507.8 | 79.0 | 12,216.0 | 452.5 | 12,668.5 |
| Net income | — | — | 66.6 | — | — | — | — | 66.6 | 45.5 | 112.2 |
| Other comprehensive income | — | — | — | — | 1,221.0 | 211.7 | -16.3 | 1,416.5 | -7.5 | 1,409.0 |
| Net profit for the period | — | — | 66.6 | — | 1,221.0 | 211.7 | -16.3 | 1,483.2 | 38.0 | 1,521.2 |
| Dividends paid/resolved | — | — | -440.0 | — | — | — | — | -440.0 | -27.4 | -467.5 |
| Other changes6 | 0.0 | 0.0 | — | — | — | — | — | 0.0 | 12.7 | 12.7 |
| As at December 31, 2022 | 512.0 | 4,155.6 | 9,910.5 | -311.8 | -773.9 | -296.1 | 62.7 | 13,259.1 | 475.8 | 13,735.0 |
| Net income | — | — | 1,156.4 | — | — | — | — | 1,156.4 | 37.5 | 1,193.9 |
| Other comprehensive income | — | — | — | — | -219.1 | -159.9 | -61.8 | -440.8 | -37.2 | -478.0 |
| Net profit for the period | — | — | 1,156.4 | — | -219.1 | -159.9 | -61.8 | 715.6 | 0.3 | 715.9 |
| Dividends paid/resolved | — | — | -300.0 | — | — | — | — | -300.0 | -23.8 | -323.8 |
| Successive purchases | — | — | — | 1.1 | — | — | — | 1.1 | -1.0 | 0.1 |
| Other changes6 | — | — | — | 0.1 | — | — | — | 0.1 | -2.1 | -2.0 |
| As at December 31, 2023 | 512.0 | 4,155.6 | 10,766.9 | -310.6 | -992.9 | -456.0 | 0.9 | 13,675.9 | 449.2 | 14,125.1 |
1 Divided into 200,005,983 (PY: 200,005,983) outstanding shares with dividend and voting rights.
2 Includes an amount of €1.1 million (PY: —) from successive purchases of shares in fully consolidated subsidiaries and an amount of €0.1 million (PY: —) relating to effects from the first-time consolidation of previously non-consolidated subsidiaries.
3 Includes shareholder’s portion of €0.2 million (PY: €0.1 million) in non-realized gains and losses from pension obligations of equity-accounted investees.
4 Includes shareholder’s portion of €0.1 million (PY: €1.1 million) in the currency translation of equity-accounted investees.
5 The change in the difference arising from financial instruments, including deferred taxes, was due to other investments of -€61.8 million (PY: -€16.3 million).
6 Other changes in non-controlling interests due to changes in the scope of consolidation and capital increases.
